Retractable Technologies (RVP) Competitors

$0.71 0.00 (0.00%)

Closing price 05/22/2026 04:00 PM Eastern

Extended Trading

$0.72 +0.00 (+0.28%)

As of 05/22/2026 05:42 PM Eastern

RVP vs. OM, STSS, MDAI, LNSR, and BDMD

Should you buy Retractable Technologies stock or one of its competitors? MarketBeat compares Retractable Technologies with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Retractable Technologies include Outset Medical (OM), Sharps Technology (STSS), Spectral AI (MDAI), LENSAR (LNSR), and Baird Medical Investment (BDMD). These companies are all part of the "medical equipment" industry.

How does Retractable Technologies compare to Outset Medical?

Outset Medical (NASDAQ:OM) and Retractable Technologies (NYSE:RVP) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, risk, analyst recommendations, profitability, valuation, dividends, institutional ownership and media sentiment.

7.6% of Retractable Technologies shares are owned by institutional investors. 2.5% of Outset Medical shares are owned by insiders. Comparatively, 59.5% of Retractable Technologies shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

In the previous week, Outset Medical had 5 more articles in the media than Retractable Technologies. MarketBeat recorded 5 mentions for Outset Medical and 0 mentions for Retractable Technologies. Outset Medical's average media sentiment score of -0.22 beat Retractable Technologies' score of -1.00 indicating that Outset Medical is being referred to more favorably in the media.

Company	Overall Sentiment
Outset Medical	Neutral
Retractable Technologies	Negative

Outset Medical currently has a consensus target price of $10.00, suggesting a potential upside of 131.48%. Given Outset Medical's stronger consensus rating and higher possible upside, equities analysts plainly believe Outset Medical is more favorable than Retractable Technologies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Outset Medical	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40
Retractable Technologies	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Retractable Technologies has a net margin of -41.11% compared to Outset Medical's net margin of -63.65%. Retractable Technologies' return on equity of -17.15% beat Outset Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Outset Medical	-63.65%	-56.13%	-27.45%
Retractable Technologies	-41.11%	-17.15%	-9.33%

Retractable Technologies has lower revenue, but higher earnings than Outset Medical. Retractable Technologies is trading at a lower price-to-earnings ratio than Outset Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Outset Medical	$119.48M	0.67	-$81.65M	-$4.16	N/A
Retractable Technologies	$37.15M	0.57	-$7.01M	-$0.21	N/A

Outset Medical has a beta of 1.92, suggesting that its share price is 92% more volatile than the broader market. Comparatively, Retractable Technologies has a beta of 1.25, suggesting that its share price is 25% more volatile than the broader market.

Summary

Outset Medical beats Retractable Technologies on 9 of the 16 factors compared between the two stocks.

How does Retractable Technologies compare to Sharps Technology?

Retractable Technologies (NYSE:RVP) and Sharps Technology (NASDAQ:STSS) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, profitability, risk, analyst recommendations, media sentiment, institutional ownership, dividends and earnings.

Retractable Technologies has higher revenue and earnings than Sharps Technology. Retractable Technologies is trading at a lower price-to-earnings ratio than Sharps Technology, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Retractable Technologies	$37.15M	0.57	-$7.01M	-$0.21	N/A
Sharps Technology	$200K	383.00	-$282.50M	-$1.63	N/A

In the previous week, Sharps Technology's average media sentiment score of -0.63 beat Retractable Technologies' score of -1.00 indicating that Sharps Technology is being referred to more favorably in the news media.

Company	Overall Sentiment
Retractable Technologies	Negative
Sharps Technology	Negative

Retractable Technologies has a beta of 1.25, suggesting that its share price is 25% more volatile than the broader market. Comparatively, Sharps Technology has a beta of 2.03, suggesting that its share price is 103% more volatile than the broader market.

Sharps Technology has a net margin of 0.00% compared to Retractable Technologies' net margin of -41.11%. Retractable Technologies' return on equity of -17.15% beat Sharps Technology's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Retractable Technologies	-41.11%	-17.15%	-9.33%
Sharps Technology	N/A	-157.91%	-154.40%

7.6% of Retractable Technologies shares are held by institutional investors. Comparatively, 17.2% of Sharps Technology shares are held by institutional investors. 59.5% of Retractable Technologies shares are held by company insiders. Comparatively, 1.2% of Sharps Technology shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Retractable Technologies	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Sharps Technology	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Summary

Sharps Technology beats Retractable Technologies on 7 of the 13 factors compared between the two stocks.

How does Retractable Technologies compare to Spectral AI?

Retractable Technologies (NYSE:RVP) and Spectral AI (NASDAQ:MDAI) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, media sentiment, valuation, institutional ownership, risk, profitability, analyst recommendations and dividends.

Retractable Technologies has a net margin of -41.11% compared to Spectral AI's net margin of -85.58%. Spectral AI's return on equity of 0.00% beat Retractable Technologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Retractable Technologies	-41.11%	-17.15%	-9.33%
Spectral AI	-85.58%	N/A	-72.97%

7.6% of Retractable Technologies shares are owned by institutional investors. Comparatively, 67.1% of Spectral AI shares are owned by institutional investors. 59.5% of Retractable Technologies shares are owned by company insiders. Comparatively, 13.7% of Spectral AI shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Retractable Technologies has a beta of 1.25, indicating that its share price is 25% more volatile than the broader market. Comparatively, Spectral AI has a beta of 1.16, indicating that its share price is 16% more volatile than the broader market.

Spectral AI has a consensus target price of $3.00, indicating a potential upside of 11.94%. Given Spectral AI's stronger consensus rating and higher possible upside, analysts plainly believe Spectral AI is more favorable than Retractable Technologies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Retractable Technologies	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Spectral AI	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Retractable Technologies has higher revenue and earnings than Spectral AI. Spectral AI is trading at a lower price-to-earnings ratio than Retractable Technologies, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Retractable Technologies	$37.15M	0.57	-$7.01M	-$0.21	N/A
Spectral AI	$19.65M	4.34	-$7.57M	-$0.53	N/A

In the previous week, Spectral AI had 6 more articles in the media than Retractable Technologies. MarketBeat recorded 6 mentions for Spectral AI and 0 mentions for Retractable Technologies. Spectral AI's average media sentiment score of 0.35 beat Retractable Technologies' score of -1.00 indicating that Spectral AI is being referred to more favorably in the news media.

Company	Overall Sentiment
Retractable Technologies	Negative
Spectral AI	Neutral

Summary

Retractable Technologies and Spectral AI tied by winning 8 of the 16 factors compared between the two stocks.

How does Retractable Technologies compare to LENSAR?

Retractable Technologies (NYSE:RVP) and LENSAR (NASDAQ:LNSR) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, profitability, analyst recommendations, media sentiment, earnings, risk, valuation and dividends.

Retractable Technologies has a beta of 1.25, indicating that its share price is 25% more volatile than the broader market. Comparatively, LENSAR has a beta of 0.84, indicating that its share price is 16% less volatile than the broader market.

7.6% of Retractable Technologies shares are held by institutional investors. Comparatively, 40.2% of LENSAR shares are held by institutional investors. 59.5% of Retractable Technologies shares are held by insiders. Comparatively, 66.0% of LENSAR shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

LENSAR has a consensus target price of $10.00, suggesting a potential upside of 64.20%. Given LENSAR's stronger consensus rating and higher probable upside, analysts plainly believe LENSAR is more favorable than Retractable Technologies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Retractable Technologies	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
LENSAR	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33

In the previous week, LENSAR's average media sentiment score of 0.00 beat Retractable Technologies' score of -1.00 indicating that LENSAR is being referred to more favorably in the news media.

Company	Overall Sentiment
Retractable Technologies	Negative
LENSAR	Neutral

Retractable Technologies has higher earnings, but lower revenue than LENSAR. LENSAR is trading at a lower price-to-earnings ratio than Retractable Technologies, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Retractable Technologies	$37.15M	0.57	-$7.01M	-$0.21	N/A
LENSAR	$58.44M	1.26	-$34.28M	-$0.58	N/A

LENSAR has a net margin of 50.94% compared to Retractable Technologies' net margin of -41.11%. Retractable Technologies' return on equity of -17.15% beat LENSAR's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Retractable Technologies	-41.11%	-17.15%	-9.33%
LENSAR	50.94%	-183.19%	42.26%

Summary

LENSAR beats Retractable Technologies on 10 of the 15 factors compared between the two stocks.

How does Retractable Technologies compare to Baird Medical Investment?

Retractable Technologies (NYSE:RVP) and Baird Medical Investment (NASDAQ:BDMD) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their analyst recommendations, institutional ownership, risk, media sentiment, profitability, valuation, dividends and earnings.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Retractable Technologies	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Baird Medical Investment	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Retractable Technologies has a beta of 1.25, suggesting that its stock price is 25% more volatile than the broader market. Comparatively, Baird Medical Investment has a beta of -1.18, suggesting that its stock price is 218% less volatile than the broader market.

In the previous week, Baird Medical Investment's average media sentiment score of 0.00 beat Retractable Technologies' score of -1.00 indicating that Baird Medical Investment is being referred to more favorably in the news media.

Company	Overall Sentiment
Retractable Technologies	Negative
Baird Medical Investment	Neutral

Baird Medical Investment has a net margin of 0.00% compared to Retractable Technologies' net margin of -41.11%. Baird Medical Investment's return on equity of 0.00% beat Retractable Technologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Retractable Technologies	-41.11%	-17.15%	-9.33%
Baird Medical Investment	N/A	N/A	N/A

7.6% of Retractable Technologies shares are owned by institutional investors. Comparatively, 19.8% of Baird Medical Investment shares are owned by institutional investors. 59.5% of Retractable Technologies shares are owned by insiders. Comparatively, 78.9% of Baird Medical Investment shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Baird Medical Investment has lower revenue, but higher earnings than Retractable Technologies.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Retractable Technologies	$37.15M	0.57	-$7.01M	-$0.21	N/A
Baird Medical Investment	$22.54M	2.96	N/A	N/A	N/A

Summary

Baird Medical Investment beats Retractable Technologies on 8 of the 10 factors compared between the two stocks.

Get Retractable Technologies News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding RVP and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

RVP vs. The Competition

Export

Metric	Retractable Technologies	Surgical & medical instruments Industry	Medical Sector	NYSE Exchange
Market Cap	$21.35M	$53.33M	$6.46B	$23.20B
Dividend Yield	N/A	1.08%	2.76%	4.10%
P/E Ratio	-1.32	18.68	21.00	30.65
Price / Sales	0.57	37.51	562.18	24.50
Price / Cash	48.25	18.87	43.49	25.12
Price / Book	0.22	16.15	10.41	4.74
Net Income	-$7.01M	-$20.25M	$3.57B	$1.07B
7 Day Performance	4.70%	2.27%	6.40%	2.36%
1 Month Performance	11.93%	-12.00%	3.54%	1.58%
1 Year Performance	9.86%	-2.39%	34.14%	28.42%

Retractable Technologies Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
RVP Retractable Technologies	N/A	$0.71 flat	N/A	+9.9%	$21.35M	$37.15M	N/A	240	Negative News Gap Down High Trading Volume
OM Outset Medical	2.499 of 5 stars	$4.38 +13.5%	$10.00 +128.3%	-75.9%	$81.22M	$119.48M	N/A	520
STSS Sharps Technology	0.5596 of 5 stars	$1.85 +4.2%	N/A	-55.3%	$78.08M	$200K	N/A	3	Gap Up
MDAI Spectral AI	1.5992 of 5 stars	$2.44 +2.7%	$3.00 +23.2%	+83.6%	$77.49M	$16.93M	N/A	83
LNSR LENSAR	1.6443 of 5 stars	$5.87 +1.2%	$10.00 +70.4%	-55.1%	$71.02M	$58.44M	N/A	110

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:RVP) was last updated on 5/26/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Retractable Technologies (RVP) Competitors

RVP vs. OM, STSS, MDAI, LNSR, and BDMD

How does Retractable Technologies compare to Outset Medical?

Summary

How does Retractable Technologies compare to Sharps Technology?

Summary

How does Retractable Technologies compare to Spectral AI?

Summary

How does Retractable Technologies compare to LENSAR?

Summary

How does Retractable Technologies compare to Baird Medical Investment?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

RVP vs. The Competition

Retractable Technologies Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Retractable Technologies (RVP) Competitors

RVP vs. OM, STSS, MDAI, LNSR, and BDMD

How does Retractable Technologies compare to Outset Medical?

Do institutionals and insiders hold more shares of OM or RVP?

Does the media refer more to OM or RVP?

Do analysts prefer OM or RVP?

Is OM or RVP more profitable?

Which has preferable valuation & earnings, OM or RVP?

Which has more risk & volatility, OM or RVP?

Summary

How does Retractable Technologies compare to Sharps Technology?

Which has better valuation & earnings, RVP or STSS?

Does the media prefer RVP or STSS?

Which has more volatility and risk, RVP or STSS?

Is RVP or STSS more profitable?

Do institutionals & insiders hold more shares of RVP or STSS?

Do analysts rate RVP or STSS?

Summary

How does Retractable Technologies compare to Spectral AI?

Is RVP or MDAI more profitable?

Do insiders & institutionals believe in RVP or MDAI?

Which has more risk and volatility, RVP or MDAI?

Do analysts prefer RVP or MDAI?

Which has preferable earnings & valuation, RVP or MDAI?

Does the media favor RVP or MDAI?

Summary

How does Retractable Technologies compare to LENSAR?

Which has more volatility and risk, RVP or LNSR?

Do institutionals and insiders have more ownership in RVP or LNSR?

Do analysts prefer RVP or LNSR?

Does the media favor RVP or LNSR?

Which has stronger valuation and earnings, RVP or LNSR?

Is RVP or LNSR more profitable?

Summary

How does Retractable Technologies compare to Baird Medical Investment?

Do analysts recommend RVP or BDMD?

Which has more risk and volatility, RVP or BDMD?

Does the media prefer RVP or BDMD?

Is RVP or BDMD more profitable?

Do institutionals & insiders have more ownership in RVP or BDMD?

Which has stronger valuation & earnings, RVP or BDMD?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

RVP vs. The Competition

Retractable Technologies Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools